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RESUMEN
Transporte en sangre y efectos genómicos de los
componentes del aceite de oliva.
Estudios epidemiológicos asocian el consumo de una dieta
rica en aceite de oliva (virgen extra) con una baja incidencia de
enfermedades crónicas, como las enfermedades cardiovascula-
res y el cáncer. Una concentración elevada de triglicéridos en
plasma, tanto en ayunas como durante el metabolismo postpran-
dial, está implicada en la patogénesis cardiovascular. Se ha de-
mostrado que el aceite de oliva contribuye a modular los procesos
metabólicos relativos a la secreción y al transporte de triglicéri-
dos. Con respecto a otros aceites comestibles, el aceite de oliva
genera lipoproteínas intestinales ricas en triglicéridos que se me-
tabolizan con rapidez. En este contexto, se produce un aflujo ma-
sivo de lipoproteínas nacientes y remanentes, así como de
metabolitos lipídicos y componentes liposolubles, que interaccio-
nan con células hepáticas y de tejidos extra-hepáticos. La res-
puesta celular a la dieta implica multitud de productos génicos,
incluyendo proteínas asociadas a la síntesis de lípidos, oxidación
y diferenciación celular. Se conoce el efecto beneficioso de los
ácidos grasos y otros componentes menores en la regulación
transcripcional de una gran variedad de genes. En esta revisión
se reafirma la importancia de una dieta rica en aceite de oliva vir-
gen extra en la prevención de las enfermedades cardiovasculares
y otras.
PALABRAS-CLAVE: Aceite de oliva; Ácidos grasos monoin-
saturados; Compuestos menores; Secreción intestinal; Trans-
porte de lipoproteínas; Respuesta celular; Genes; Dieta
Mediterránea.
SUMMARY
Blood transport and genomic effects of olive oil com-
ponents.
Epidemiological studies suggest that consuming diets rich in
(extra virgin) olive oil is associated with a low incidence of chronic
diseases, including cardiovascular disease and cancer. Recent
evidence has emerged which implicates raised concentrations of
plasma triglycerides in the pathogenesis of coronary artery disease
(CAD). It has been demonstrated that olive oil contributes to
modulate metabolic processes related to secretion and transport of
triglycerides. Intestinal triglyceride-rich lipoproteins from olive oil are
very efficiently cleared during postprandial metabolism compared to
other oils. Then, there is a massive interaction of nascent and
remnant triglyceride-rich lipoproteins, as well as lipid metabolites
and fat-soluble components, with hepatic and non-hepatic tissues. A
diet-related response involves a multitude of gene products,
including proteins implicated in lipid synthesis, oxidation and cell
differentiation. Particularly, it has been reported a health beneficial
effect of several components from (extra virgin) olive oil (fatty acids
and minor compounds), which are functioning as regulators of gene
transcription. This review reaffirm that a dierich in extra virgin olive
oil is of vital importance in the prevention of cardiovascular and
other diseases.
KEY-WORDS: Olive oil; Monounsaturated fatty acids; Mi-
nor compounds; Intestinal secretion; Lipoproteins transport;
Cellular response; Genes; Mediterranean diet.
1. INTRODUCTION
Recent evidence has emerged which implicates
raised concentrations of plasma triglycerides in the
pathogenesis of coronary artery disease (CAD).
Exaggerated triglyceride responses to standard
fat-containing meals have been shown in subjects
with CAD and in offspring with a parental history of
premature CAD. The lower rate of CVD in Southern
Europe suggests a potential role of the traditional
Mediterranean diet in the prevention of CVD.
Zampelas et al. (1998) have previously shown no
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difference in postprandial triglyceride response to
meals of varying monounsaturated (MUFA) and
saturated (SFA) fatty acid content in Northern
European men. Later studies they set out to determine
whether the same response was observed in Southern
European men whose habitual background diet was
high in MUFA. Both populations showed similar lipemic
responses when meals of varying MUFA and SFA
content were fed, but they unexpectedly observed
very different postprandial patterns of triglyceride
response in the two European populations.
The Mediterranean diet has become a cultural
model for dietary improvement. It is characterised by
the use of olive oil as the major culinary fat, which is
rich in MUFA. In addition, extra virgin olive oil
contains a number of phenolic compounds, which via
their antioxidant and other potent biological activities
could partially account for the observed healthful
effects of the traditional Mediterranean Diet.
Traditional Mediterranean Diet is constituted,
mainly, plenty of fresh vegetables, fruit, grains and
(extra virgin) olive oil with moderate consumption of
wine (mainly red wine) and dairy products (mainly
cheese). However, there is considerable debate
about the nutrients responsible for health effects of a
diet. The low SFA/high MUFA content has received
considerable attention. The epidemiological evidence
of a lower incidence of CHD in the Mediterranean
area also led to the hypothesis of a protective effect
of some (extra virgin) olive oil phenolics with respect
to chemically induced oxidation of human plasma
low-density lipoproteins (LDL), one of steps in the
initiation of atherosclerosis (Steinberg et al., 1989).
In both cases, fatty acids (as triglycerides, whose
fatty acid composition partially depends on the olive
oil fatty acid composition) and minor compounds (in
free or conjugated forms) have to be transported in
blood and to reach hepatic and extra-hepatic
systems.
2. SECRETION OF LIPOPROTEINS BY THE
   ENTEROCYTE
The function of chylomicron (CM) and very-low
density lipoproteins (VLDL) is to pack the absorbed
dietary lipids and fat-soluble components, stabilising
Chylomicrons VLDL
Sources Intestine only Both intestine and liver
Density <0.95 g/mL 0.95-1.006 g/mL
Sdverdberg floation (Sf) >400 20-400
Size 80-500 nm 30-80 nm
Approximate weight (KD) 50-1000x103 10-80x103
Total lipids 97-98% of particle mass 90% of particle mass
Triglycerides »95% »40%
Cholesterol »1% »15%
Phospholipids »4% »15%
Total protein 2% of particle mass 10% of particle mass
Major apolipoprotein
components
B-48, A-I, A-IV, A-II Probably similar to
chylomicrons
(B-100 instead B-48)
Minor apolipoprotein
components
C and E (both acquired
through interaction with
other plasma lipoproteins)
Same as chylomicrons
Table 1
Characteristics of intestinal lipoproteins: chylomicrons and very-low density lipoproteins (VLDL)
(adapted from Mu and Hoy, 2004)
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them for transport in the aqueous plasma
environment. Although plasma VLDL are mainly
synthesized in the liver, there is incoming evidence
that fasting intestine also produces these particles,
which do not mix readily in individual Golgi vesicles
(Mu and Hoy, 2004). Characteristics of these
lipoproteins are detailed in Table 1.
Briefly, triglyceride-rich lipoproteins are spherical
particles synthesised by intestinal epithelial cells
(Luchoomun and Hussain, 1999), being CM higher
(100 nm) than VLDL (25-80 nm). Another
classification attends to the Svedberg flotation (Sf)
rate, which defines CM as those lipoproteins that
exceed 400 Sf and VLDL as those with Sf rate of
20-400. The major lipid components are triglycerides,
cholesterol esters, free cholesterol and
phospholipids. Attending to their distribution in the
CM particle, amphipathic molecules form a
monolayer that stabilises the lipid core that also
contains dietary fat-soluble components. VLDL differ
from CM in their density, size, lipid and protein
content and composition.
Studies by Luchoomun and Hussain (1999) have
shown that in the distribution of lipids in the
intestine-assembled lipoproteins, triglyceride-rich
lipoproteins contain higher amounts of preformed
phospholipids compared with nascent phospholipids.
However, VLDL contain similar amounts of
preformed and nascent triglycerides, whereas CM
rather contain higher amounts of nascent
triglycerides. This is why the fatty acid composition of
triglycerides, but not of phospholipids, reflects the
composition of dietary triglycerides in CM.
Apolipoproteins constitute the protein fraction in
lipoproteins and play a major role in their metabolism.
Triglyceride-rich lipoproteins contain several different
apolipoproteins, including apo B-48, apo B-100, apo
AI, apo AIV, apo AII, apo C and apo E (the two last
ones are acquired later) (Table 1). There are
differences in the relative content of apolipoproteins
between CM and intestinal VLDL. For instance, apo
A-IV comprises about 40% of intestinal VLDL, but
only 10% of apo A-IV is present in CM. Human
enterocytes have the potential to secrete both apo
B-48 and apo B-100, which differ in apoB mRNA
post-transcriptional processes. Two approaches
have been described to explain the production of
apoB and apoB-containing lipoproteins. The first one
involves the introduction of a unique RNA editing
enzyme, the apoB mRNA editing enzyme catalytic
polypeptide-1 (apobec-1) that gives a stop codon at
codon 2153, resulting in synthesis of a protein which
is 48% of the apo B-100 molecule. The second one
relates the assembly and intracellular sorting of
apoB-containing lipoproteins and the inhibition of
lipid addition to apo B-100 (Innerarity et al., 1996).
Apolipoproteins B have also a critical role in the
assembly of triglyceride-rich lipoproteins, because
apo B-48 and apo B-100 bind differently to LDL
receptor (van Greevenbroek and de Bruin, 1998a). A
general belief is that apo B-100 is exclusive of VLDL,
as liver VLDL can only content apo B-100, but the
truth is that large CM can contain both apo B-48 and
apo B-100 (Luchoomun and Hussain, 1999).
It has been described that pathways for
triglyceride synthesis influence the amount of apo B
in the secreted triglyceride-rich lipoproteins (Mu and
Hoy, 2004). The ‘‘triglyceride synthetase’’ pathway
(predominant in the feeding state) produces larger
particles with lesser apolipoprotein content, whereas
he phosphatidic acid pathway (predominant in the
fasting state) produces smaller particles with twice
as much apolipoprotein per gram of fat than the
former pathway.
3. INFLUENCE OF OLIVE OIL ON POSTPRANDIAL
   LIPOPROTEINS TRANSPORT
Intestinal chylomicrons (CM) and VLDL transport
dietary fat but also triglycerides from endogenous
sources (Shiau et al., 1985). Endogenous
triglycerides come in part from circulating fatty acids
and remnant CM taken up by enterocytes, and do
not readily enter in the CM secretory pathway. That is
why the fatty acid composition of CM triglycerides
closely reflects that of dietary triglycerides (Mu and
Hoy, 2004).
The composition and structures of dietary
triglycerides determine intestinal absorption and
lipoprotein secretion (Aoe t al., 1997). After
stomach infusion of 1,3-dioleoyl-2-palmitoyl glycerol
(OPO) and 1,2-dioleoyl-3-palmitoyl glycerol (OOP),
the mean diameter of CM containing OPO are larger
than those carrying OOP. OPO is better absorbed
and transported than OOP. Other parameters related to
composition of dietary triglycerides are the size and
number of postprandial lipoproteins. The unsaturation
degree of fatty acids tends to increase the size of CM
(Sakr et al., 1997). Even, the configuration of double
bonds can condition the size of postprandial
lipoproteins (van Greevenbroek et al., 1998b).
Particularly, olive oil increases the number of CM
compared with other oils, including saturated, n-6
and n-3 polyunsaturated-enriched oils (Jackson et
al., 2002). Possible mechanisms could imply the
modulation in the enterocytes of the activity or
expression of microsomal triglyceride transfer protein
(MTP), or mRNA editing enzyme that involves the
co-translational enrichment in lipids of apo B and
further lipidation of the primordial particle along the
secretory pathway (van Greevenbroek et al., 1998c).
Therefore, olive oil could be enabling the stabilization of
the nascent CM particles with smaller lipid droplets by
affecting the enzymes involved in the lipoprotein
assembly. Indeed, unsaturated fatty acids, especially
oleic acid, are more efficiently incorporated into
lipoproteins by MTP (van Greevenbroek et al., 1996).
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The size and number of CM influence their fate
and rate of clearance. Large CM are preferentially
hydrolyzed by lipoprotein lipase (LPL), which
produces remaining cholesterol ester-rich particles
(remnant CM) after the removal of 70-90% of
triglycerides. Remnant particles interact with hepatic
lipase (HL) that further hydrolyses triglycerides and
phospholipids, preparing remnant to be up taken by
liver receptor-mediated process (Sultan e  al., 1990).
It has been suggested that CM from olive oil are
poorly hydrolysed by LPL due to the greater particle
number, but rapidly removed by HL (Jackson et al.,
2002). Certainly, olive oil contributes to modulate
metabolic processes related to secretion and
transport of triglycerides.
4. INFLUENCE OF OLIVE OIL ON POSTPRANDIAL
   LIPOPROTEINS CLEARANCE
Endothelial cells by the heparan sulphate
proteoglycan-dependent LPL and the endothelial
lipase (EL) initially participate in the clearance of
postprandial triglyceride-rich lipoproteins. LPL (with
mainly acylglycerol hydrolase activity) and EL (with
mainly phospholipase activity) co-ordinately remodel
the surface of CM. This step is essential for
accessing the CM triglyceride core. The largest CM
have the highest affinity for LPL (Xiang et al., 1999).
The action of the LPL produces free fatty acids (FFA)
and monoglycerides (MG), turning CM into remnant
lipoproteins. Moreover, the amount of soluble LPL is
proportional to the amount of triglycerides in plasma
(Heeren et al., 2002). It is interesting to note that CM
with PUFA have faster lipolysis than CM with SFA
(Chung et al., 1998). The activity of pre-heparin LPL
is sensitive to dietary fatty acids, enhancing in the
presence of n-3 PUFA (Park et al., 2003). In addition,
EL bound to postprandial lipoproteins facilitates the
hepatic clearance independently of its catalytic
function (Heeren et al., 2002).
Olive oil increases the amount of postprandially
nascent and remnant triglyceride-rich lipoproteins
compared with other fats, including safflower oil and
milk fat (Higashi et al., 1997). Similar findings have
been described by Mekki et al. (2002), who found
that a meal rich in butter has lower postprandial
lipemic response than sunflower and olive oils. The
time to reach the triglyceride postprandial peak is
also higher with olive oil (Jackson et al., 2002).
CM-triglycerides from olive oil are very efficiently
cleared during postprandial metabolism compared to
other MUFA-containing oils, which depends on the
distribution of fatty acids into triglyceride and
phospholipids molecules (Abia et al., 2003). Oleic
acid (18:1n-9) is the main fatty acid found in the
phospholipids of postprandial triglyceride-rich
lipoproteins after a meal rich in olive oil, whereas
stearic (18:0) and linoleic (18:2n-6) acids are those
found with a meal rich in high-oleic sunflower oil and
exhibit higher time of clearance. This metabolic
process is also regulated by the nature of carried
triglycerides, being more quickly removed OOO
(triolein) followed by POO (palmitoyl-dioleoyl
glycerol) and OOL (dioleoyl-linoleoyl glycerol) (Abia
et al., 1999).
5. ROLE OF APOLIPOPROTEINS AND
   RECEPTORS ON MECHANISMS INVOLVED
   IN POSTPRANDIAL LIPOPROTEINS
   CLEARANCE
The mechanisms related to postprandial
lipoproteins clearance are not well understood
nowadays. The nascent CM are loaded with apo
B-48. The nature of dietary fats modulates the
expression of apo B-48. By using olive oil in a human
model of postprandial metabolism, Abia et al. (2003)
suggested that CM-phospholipids might interact with
distinct cellular receptors to facilitate their
incorporation. This agrees with the discovery of a
novel and a uniquely receptor for apo B-48 in the
uman monocyte/macrophage line THP-1 and
endothelial cells (Gianturco et al., 1999; Brown et al.,
2000). It is of major importance for the knowledge of
atherosclerosis development because macrophages
loaded with triglyceride-rich lipoproteins, as
oxidised-LDL, can turn on foam cells in the arterial
intima (Gianturco et al., 1999). Apo B-48 receptor is
a non-heparan sulphate-dependent dimmer (200
and 235 KDa) (Bradley et al., 1999). When
heterologous expression of apo B-48 receptor is
promoted in CHO cells, they become apparent as
foam cells after incubation with triglyceride-rich
lipoproteins (Brown et al., 2000; Brown et al., 2002).
Unfortunately, we have no data on the effects of olive
oil in the expression and activity of the receptor.
Apolipoproteins E are also involved in the
learance of lipoproteins. There are three main
polymorphisms of apo E: E2, E3 and E4. E3 allele is
present in 77% of the population and previous
tudies shown that correlates with plasma lipid
profile. Over-expression of apo E3 in transgenic
animals increases the level in plasma of total
cholesterol and triglycerides. It appears that apo E3
leads to normolipemia, hypercholesterolemia or
combined hyperlipidemia (hypercholesterolemia and
hypertriglyceridemia) when expressed at low, medium
or high levels, respectively (Tomkin et al., 2001). E4
allele is associated with high levels in plasma of
LDL-cholesterol, whereas E2 allele prevents the
postprandial increase of plasma triglycerides
(Minihane et al., 2000) and the fasting levels of plasma
cholesterol (Larson et al., 2000).
The importance of lipids supply for extra-hepatic
tissues by CM during postprandial processes
determines the existence of a protector mechanism
from too rapid uptake by the liver. Apolipoprotein C-III
interferes with apo E binding sites at the receptors
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and inhibits the activity of apolipoprotein C-II, an
activator of LPL. These apolipoproteins are not
formed in the enterocytes, but are constituent of the
high-density lipoproteins (HDL). MUFA-rich diets
increase the content of apo E in postprandial
triglyceride-rich lipoproteins (Madigan et al., 2000). It
is not known whether olive oil can modify the apo
C-III/apo C-II ratio.
6. SECRETION OF LIPOPROTEINS BY THE
   LIVER
The liver quickly metabolizes the postprandial
remnant lipoproteins. Those of size smaller than 100
nm are up taken by hepatocytes in the space of
Disse (Fraser et al, 1995). Larger triglyceride-rich
lipoproteins re-circulate over the peripheral tissues.
In the liver, triglycerides can be used for energy and
cholesterol for the biosynthesis of membranes,
conferring the optimal fluidity to their physiological
functions. Throughout the postprandial metabolism,
the liver secretes new triglyceride-rich lipoproteins
(VLDL) to the blood circulation. This process occurs
usually after 5-6 hours post-meal period (Abia et al.,
1999).
MTP mediates the formation of VLDL in
hepatocytes, by regulating triglyceride accumulation
in the microsomal lumen and triglyceride assembly
with apo B-100 (Kulinski et al., 2002). A deficiency in
MTP causes abetalipoproteinemia, but up-regulation
of MTP has been shown to increase the amount of
triglycerides in VLDL (Liao et al., 1999). Nascent
VLDL touch with small lipoproteins charged with apo
E and apo C-II (HDL), activating LPL and HL. The
size of VLDL diminishes and lipoproteins turn on
intermediary-density lipoproteins (IDL) and finally on
LDL, the remnant particle of VLDL. LDL contains
large amounts of cholesterol and almost none of
triglycerides (Chapell t al., 1998). Independently of
its lipolytic activity, HL promotes the hepatic uptake
of remnants and IDL particles (Perret et al., 2002;
Zambon et al., 2003).
The expression and secretion of apo B-100
correlate with the pool of fatty acids in the
hepatocytes. Particularly, oleic acid increases (29
%) the amount of apo B-100 in the medium of
hepatoma cells, with no change in triglyceride
synthesis (Arrol et al., 2000). VLDL particles
secreted had lower density compared to other
unsaturated fatty acids, such as linoleic,
arachidonic (20:4n-6) and eicosapentaenoic
(20:5n-3) acids, and SFA, such as lauric (12:0),
myristic (14:0), palmitic (16:0) and arachidic (20:0)
acids. All fatty acids, except stearic and a-linolenic
(18:3n-3) acids, were stimulators of apo B and
VLDL secretion. In addition, MUFA and PUFA were
more potent than SFA.
The composition of VLDL may be modulated, at
least partially, by the nature of triglycerides coming
from the diet. In fact, it is well accepted that dietary
fatty acids have influence at long-term on the fatty
acid composition of cholesterol esters and
phospholipids in LDL (Sarkkinen t al., 1994).
7. METABOLIC EFFECTS OF OLIVE OIL
Epidemiological studies suggest that consuming
diets rich in (extra virgin) olive oil is associated with a low
incidence of chronic disease, including cardiovascular
disease and cancer. However, the effects of olive oil on
health and disease cannot be understood without a
profound understanding of how (extra virgin) olive oil
components act at the cellular level.
The development of a diet-related disease
involves a multitude of gene products, including
proteins involved in lipid synthesis and oxidation,
thermogenesis and cell differentiation. Nutrients we
consume are among the most influential
environmental factors that govern the expression of
genes encoding these proteins. Nutrients govern the
tissue content and activity of different proteins by
functioning as regulators of gene transcription,
nuclear RNA processing, mRNA degradation and
mRNA translation, as well as functioning as
post-translational modifiers of proteins.
The regulation of cell functions by fatty acids and
minor compounds from (extra virgin) olive oil can
occur on two general levels, modulation of signal
transduction via manipulation of membrane fatty acid
composition (non-genomic effect) and rapid and
direct modification of gene transcription (genomic
effect).
The initiation of gene transcription is a complex and
tightly regulated process in which transcription factors,
upon the appropriate stimuli, recognize and bind to
specific DNA sequence motifs in the promoter region of
the target gene. Upon this binding, mRNA for that
particular gene is transcribed, and accumulation of
its gene product begins. Transcription factors can be
activated by phosphorylation, translocation of
inactive complexes or synthesis de novo by other
transcription factors.
7.1. Non-genomic effects of olive oil
Olive oil phenols interfere with leukotriene
generation by inhibiting 5-lipoxygenase and
12-lipoxygenase activities in macrophages
(Kohyama et al., 1997), but not cyclooxygenase
(COX) activity. Therefore, their role in prostaglandin
biosynthesis is due not only to their action on COX
activity but also to their effects on COX levels.
Reactive oxygen species (ROS) may be involved in
the pathways that result in arachidonic acid
mobilization from membranes and PGE2 release by
COX-2. The tyrosol and b-sitosterol treatments that
inhibit ROS production can prevent COX-2
expression induced by phorbol ester (PMA).
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However, tyrosol and b-sitosterol have no effect on
COX-2 activity in a cell-free enzyme system from
macrophages stimulated by PMA (Moreno, 2003).
Taken together, these results are consistent with the
hypothesis that tyrosol and b-sitosterol inhibit
arachidonic acid cascade through ROS release
modulation. This may result from the transcriptional
or post-transcriptional regulation of mRNA stability,
which remains to be established. The promoter
region of the COX-2 gene contains several binding
sites for transcriptional factors that may be regulated
by the cellular redox state, like NF-kB (Zwacka et al.,
1998). Thus, antioxidants like tyrosol and b-sitosterol
may interfere with NF-kB. It confirms that both olive
oil minor components reduce the NF-kB activation
induced by PMA, whose interaction amplifies COX-2
promoter activation.
7.2. Genomic effects of olive oil
The following section will review transcription factors
that play a role in diet-related diseases regulated by
(extra virgin) olive oil components (Table 2).
7.2.1. NF-kB
The transcription factor NF-kB complex is present
in the cytoplasm as a heterodimer composed of
NFkB1 (p50) and Rel a (p65) subunits bound to one
of a number of inhibitory proteins called IkBs. n
response to diverse stimuli, including inflammatory
cytokines, mitogens and several viral proteins, sheer
stress and oxidative processes, NF-kB dissociates
from IkB, the p50/p65 complex translocates to the
nucleus because of the complete proteolytic
degradation of the IkB proteins. NF-kB activation has
been linked to the onset of atherosclerosis. It
activates a variety of target genes that regulate cell
proliferation and mediate cell survival as well as
genes relevant to the pathophysiology of the vessel
wall, including genes that regulate the expression of
cytokines (interferon g and b, interleukin-3,
interleukin-6, GM-CSF), chemokines, vaso-regulatory
molecules (endothelial tissue factor, nitric oxide
synthase), and leukocyte adhesion molecules
(ICAM-1, ELAM-1, VCAM-1).
The effect of olive oil on proliferation, cytokine
production and pleiotropic genes expression through
NF-kB activation has been considered beneficial or
neutral by several authors (Rusyn et al., 1999;
Verlengia et al., 2003). Thus, oleic acid does not
stimulate induction of NF-kB and therefore does not
activate endothelial cells (Henning et al., 2000;
Massaro et al., 2002). However, the effect of oleic
acid on NF-kB activation remains controversial.
Recent studies have suggested that elevated levels
of oleic and linoleic acids in plasma result in
endothelial dysfunction, through an increase in
TRANSCRIPTION
FACTOR COMPOUNDS
TARGET GENES
TRANSACTIVATED
NF-kB -Oleic acid (activation, inhibition)
-Phenolics (oleuropein, hybroxytyrosol)
(inhibition)
-ß-carotene (inhibition)
-Linoleic acid (activation)
Inflammatory
cytokines,
chemokines, vaso-
regulatory molecules,
leukocyte adhesion
molecules, genes that
regulate cell
proliferation
C-myc -Oleic and linoleic acids
-ß-carotene
-a-Tocopherol (inhibition)
Proliferation (cyclins A
and B), apoptosis and
differentiation
AP-1 -Oleic acid (inhibition)
-Linoleic and a-linolenic acid (activation)
-Phenolics, ß-carotene, a-tocopherol
(inhibition)
Proliferation, p21,
apoptosis, p53, p19,
cytokines
LXR Polyunsaturated>monounsaturated>saturated
fatty acids (pattern of inhibition)
Genes for lipoprotein
lipase, sterol
regulatory-element-
binding protein 1c,
ATP-binding cassette
transporter AI
PPARs Polyunsaturated>monounsaturated>saturated
fatty acids (pattern of affinity)
Genes involved in
lipid and glucose
metabolism
Table 2
Transcription factor pathways mediating nutrient-gene interaction
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endothelin-1 (Park et al., 2003) and vascular
adhesion molecule-1 (VCAM-1) protein expression
(Dichtl et al., 2002) via activation of protein kinase C
and NF-kB.
Phenolics present in extra virgin olive oil,
transcriptionally inhibit endothelial adhesion
molecules expression by inhibiting NF-kB activation,
partially explaining the vascular athero-protective
effect of extra virgin olive oil (Massaro et al., 2002;
Carluccio et al., 2003). Analysis of the NF-kB
activation pathways reveals that the antioxidants do
not inhibit activation of the IkB kinase activity,
degradation of IkBa, or translocation of activated
NF-kB into the nucleus, but they do block the
formation of p50/p65/DNA binding complexes (Ma et
al., 2003).
It has been recently reported that ß-carotene
induces growth-inhibitory and pro-oxidant effects,
and increases the DNA-binding activity of nuclear
proteins at NF-kB site in leukemic and colon
adenocarcinoma cells (Palozza et al., 2003). In these
cells, treatment with a-tocopherol supports the
hypothesi  that carotenoids regulate this transcription
factor through a pro-oxidant mechanism. Other minor
compounds from extra virgin olive oils have been
shown to inhibit translocation of NF-kB and interrupt
cardiac inflammatory cytokine secretion (Horton et
al., 2001).
7.2.2. c-Myc
A growing body of evidence indicates that c-Myc
can play a pivotal role in both neoplasia and
cardiovascular diseases. This protein product of
cellular proto-oncogen c-myc is widely known as one
of the essential transcription factors that perform
cellular growth, proliferation, apoptosis, cell cycle
entry and differentiation.
C-Myc is a sequence specific DNA binding
protein that has a helix-loop-helix (HLH) and a
leucine zipper (Zip) for protein dimerization and a
basic region (b) for DNA binding at its C-terminal
end. Heterodimerization of c-Myc with another
b/HLH/Zip protein Max and binding of Myc-Max
heterodimer to an E-box DNA motif [5-CA(C/T)GTC]
is a prerequisite for the transcriptional regulation and
activity of the c-Myc protein. C-Myc-Max also
controls other transcription factors by sequestering
or interacting with them, including activator protein
(AP)-2 and elongation-2 factor, which are involved in
the basal machinery of cell.
Some olive oil components may have anti-tumoral
and anti-atherogenic effects by inhibiting c-Myc
activation. Some studies have demonstrated that
c-Myc activation is an early event in lipid
accumulation within coronary arterial wall, occurring
prior to development of atherosclerosis. MUFA and
PUFA have strong inhibitory effects on the binding of
the c-Myc-Max heterodimer to an E-box DNA site.
The interaction with the protein dimmer, not with
DNA, blocks the entire c-Myc-Max-DNA complex
formation, causing anti-proliferative effects in human
cancer cells (Chung et al., 2002). Similar to NF-kB,
c-Myc is a redox-sensitive transcription factor. C-Myc
is a NF-kB target gene and is implicated in apoptosis
induction. Accordingly, ß-carotene is able to increase
the expression of c-Myc, which is directly related to
apoptosis induction (Palozza et al., 2003). Some
studies have demonstrated that a-tocopherol is able
to reduce the activation of c-Myc-dependent
signalling pathways in coronary lesions of animals
and humans (de Nigris et al., 2000; 2001).
7.2.3. AP-1
Activator protein-1 (AP-1) is a transcription factor
composed of homodimeric or heterodimeric
combinations of the transcription factor proteins Fos
and Jun, which bind to a common DNA consensus
site. The AP-1 consensus site is located in the
promoters of many genes involved in inflammatory
responses relevant to vascular pathophysiology,
including basic fibroblast growth factor (bFGF),
transforming growth factor ß (TGFß), endothelin-1
and plasminogen activator-1. AP-1 protein also
affects cell growth and survival by their ability to
transactivate the expression of genes that regulate
the cell cycle.
The process of inflammation is now believed to be
the etiological event that precedes the development
and continual process of atherosclerosis. There is
accumulating evidence that point out the beneficial
influence of extra virgin olive oil in the immune
function (Yaqoob et al., 1998; Adam et al., 2000;
Miles et al., 2001). PUFA, such as linoleic acid and to
a lesser extent a-linolenic acid, can contribute to
induction of inflammatory genes in vascular
endothelial cells via AP-1 activation. However, oleic
cid seems to have no effect or down-regulate the
activity of AP-1, resulting in a decreased
inflammatory gene mRNA (Toborek et al., 2002;
Viswanathat et al., 2003). Thus, the high ratio of
MUFA to PUFA found in olive oil may contribute to its
substantial benefit in cardiovascular diseases.
Phenolics from extra virgin olive oil at nutritionally
relevant concentrations transcriptionally inhibit
e dothelial adhesion molecular expression via
inhibition of AP-1 (Carluccio et al., 2003). Further
studies have provided molecular evidence
supporting the beneficial effect of a-tocopherol in the
development of inflammation via suppression of IL-4
expression by blocking binding of transcription
factors to IL-4 promoter binding sites for AP-1
(Li-Weber et al., 2002). ß-Carotene is also an
effective inhibitor of breast cancer, possibly mediated
through down-regulation of cell cycle regulatory
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proteins and/or inhibition of AP-1 transcriptional
activity (Tibaduiza et al., 2002).
7.2.4. Nuclear receptors
Nuclear receptors are one of the largest groups of
transcription factors, with 49 distinct members
presently identified in the human genome. Nuclear
receptors are regulators integrating different
homeostatic controls:
· Energy and glucose metabolism [peroxisome
proliferators-activated receptor gamma
(PPARl)].
· Fatty acid, triglyceride and lipoprotein
metabolism (PPARa, ß/d and g).
· Reverse cholesterol transport and cholesterol
absortion [liver X receptors (LXR) and liver
receptor homolog-1 (LRH-1)].
· Bile acid metabolism [farnesol X receptor
(FXR), LXR, LRH-1].
· Defence against xeno- and endobiotics
[pregnane X, receptor/steroid and xenobiotic
receptor (PXR/SXR)].
Nuclear receptors have a modular structure
characterized by a ligand-independent AF-1
transactivation domain in the N-terminal region, a
highly conserved DNA-binding domain composed of
two zinc fingers recognizing specific DNA
sequences, and a ligand-binding and dimerization
domain that contains a ligand-dependent AF-2
transactivation domain in its C-terminal portion. Most
nuclear receptors are active as dimmers with the
retinoid X receptor (RXR, NR2B1) and bind to
specific nucleotide sequences (response element) in
the promoter region of a large number of genes.
During ligand binding, nuclear receptors undergo a
conformational change that results in the
coordinated dissociation of co-repressors and the
recruitment of co-activator proteins to enable
transcriptional activation (Francis et al., 2003).
In the past few years, it has become clear that
fatty acids induce or inhibit the mRNA expression of
a variety of different genes by acting both, as agonist
and as antagonists for nuclear hormone receptors.
The present section briefly reviews recent data on
the mechanisms by which fatty acids influence DNA
transcription and focus especially on the importance
of two nuclear receptors, LXR and PPARs.
LXR is believed to act as a sterol sensor in cells
up-regulating genes involved in cholesterol elimination
when cells are faced with excess sterol. LXR forms
obligate heterodimers with RXR, which then enhance
the transcription of such genes as those for LPL,
SREBP-1c (sterol regulatory-element-binding protein 1
c) and ABC sterol transporters, such as ABCA1
(ATP-binding cassette transporter A1, a sterol
transporter critical for facilitating the cholesterol and
phospholipids to lipid-poor apolipoproteins, resulting
in the formation of nascent HDL particles). Two
different LXR genes have been described, LXRa and
LXRß. Fatty acids induce LXRa gene expression in
the liver (Tobin et al., 2000) and activate LXRa
transcription factor in the intestine (Murthy et al.,
2004). Furthermore, these studies have postulated
that SREBP-1c and ABCA1 are gene targets of LXR
through fatty acid activation, suggesting an important
cross-talk between fatty acids metabolism and
cholesterol regulation. The pattern of inhibition
clearly favours unsaturated fatty acids over SFA and,
in most studies, PUFA over MUFA (Hannah et al.,
2001; Ou et al., 2001). Thus, PUFA but not oleic acid
decrease both LXR-mediated SREBP-1c mass and
gene expression (Field et al., 2002). Murthy et al.
(2004) have recently shown that fatty acids decrease
the efflux of cholesterol in Caco-2 cells in response
to LXR activation, without changing (by linoleic and
stearic acids) or modestly attenuating [by oleic,
arachidonic and docosahexaenoic (22:6n-3) acids]
ABCA1 gene expression. Except for oleic acid, all
fatty acids substantially attenuated an increase in
ABCA1 mass secondary to LXR activation. The
authors suggested that oleic acid probably
decreases cholesterol efflux by diverting cholesterol
way from ABCA1 towards ACAT (acyl-
CoA:cholesterol acyltransferase). This fact would
indicate that diets enriched in oleic acid would
preferentially promote intestinal cholesterol secretion
in triglyceride-rich lipoproteins and less cholesterol
ecretion in nascent HDL.
In addition, it has become clear that induction of
gene transcription by fatty acids is often mediated by
PPARs. PPAR a is mostly expressed in brown
adipose tissue and liver; PPARß/d is present at high
concentrations in numerous tissues but it is
especially abundant in the intestine; PPARg is most
abundant in white adipose tissue and to a lesser
xtent in colon and macrophages. Some authors
have provided support for an anti-atherogenic role of
PPARg (Chawla et al., 2001; Chinetti et al., 2001).
PUFA, as well as MUFA and SFA, induce the
expression of reporter genes in a PPAR-dependent
manner. Although most fatty acids including SFA and
unsaturated fatty acids bind PPARs with low to
moderate affinity, it is not entirely clear whether their
relative affinities differ greatly. In general, all isoforms
of PPARs are more responsive to 18-22 carbon n-6
and n-3 PUFA than to MUFA and SFA. According to
Xu et al. (1999), SFA and MUFA bind to the PPARa
subtype with approximately equal affinity. The
highest binding affinity was found for linoleic acid.
8. METABOLISM AND EXCRETION OF OLIVE
   OIL MINOR COMPOUNDS
Studies on phenolics metabolism show
differences between administered doses and
excreted metabolic products in urine. It is unknown
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whether the remaining fraction is evacuated with the
faeces without be absorbed, destroyed in the gut, or
accumulated in organs or circulating cells, such as
erythrocytes. The quantities of phenolic compounds
found intact in urine vary from one to another. The
low recovery for some of them is not explained by
chemical degradation in the gut, as they have shown
a great stability in gastric or intestinal juices (Olthof et
al., 2001).
Intestinal absorption of phenolic compounds can
be high; however, the plasma concentration of any
individual molecule rarely exceeds 1 mM after the
consumption of 10-100 mg of a single compound.
The plasma antioxidant capacity suggests that more
phenolics should be present, mainly in the form of
metabolites generated by either tissues or colonic
microflora (Scalbert e al., 2000). It is assumed that
dietary doses, contrary to drug doses, do not readily
saturate the metabolic pathways and hence
circulating species would be expected to be
conjugated (Bell et al., 2000). The dose will also
determine the primary site of metabolism. Large
doses are metabolised primarily in the liver, whereas
small doses are rather metabolised by the intestinal
mucosa, with the liver playing a secondary role to
modify conjugates from the small intestine (Piskula
et al., 1998).
In the colon, the microflora can also hydrolyse
flavonoid glucuronides excreted in the bile and the
resulting aglycone reabsorbed, thus entering into an
entero-hepatic cycle (Aura et al., 2002). Aglycones
can also further be metabolised to a wide variety of
low molecular weight aromatic acids (phenylvaleric,
phenylpropionic, phenylacetic and benzoic acids),
which are well absorbed through the colonic barrier
(Deprez et al., 2000). The amount of substrates
reaching the colon and the tissue exposure to their
microbial metabolites could be highest than the
amount of the absorbed phenolic compounds
(Scalbert et al., 2002).
The metabolism of phenolic compounds implies
reactions of conjugation on aglycones, after the
hydrolysis of phenol derivatives is produced. Major
conjugation reactions include the formation of
o-glucuronides (Spencer t al., 1999; Donovan et al.,
2001), sulphate esters and o-methyl ethers (Manna
et al., 2000). They occur firstly in the gut and then in
plasma facilitating its urinary and biliary excretion
(Scalbert et al., 2002). The formation of phenol
conjugates can dramatically alter the biological
properties of the circulating metabolites.
Miro-Casas et al. (2001) quantified the amount of
excreted tyrosol in urine, reporting a maximal
concentration in the first 4 h after (extra virgin) olive
oil ingestion. Total urine recoveries were about 25%
of the ingested tyrosol, in which 6-11% consisted of
free tyrosol and the remaining as glucuronide
conjugates. Vissers et al. (2001) estimated the
human absorption of a phenol-rich supplement
obtained from (extra virgin) olive oil, finding the net
absorption >55 mol/100 mol and the re-excretion of
tyrosol and hydroxytyrosol 5-16 mol/100 mol.
Hydroxytyrosol and tyrosol are excreted in urine
as glucuronide conjugates with a positive correlation
between the amounts of phenolics ingested and
glucuronide conjugation of urine metabolites (Visioli
et al., 2000). Other metabolites of hydroxytyrosol
[homovanillic acid (4-hydroxy-3-methoxy phenylacetic
acid) and homovanillic alcohol] in humans (Caruso et
al., 2001), and oxidised and methylated derivatives of
hydroxytyrosol (3,4-dihydroxyphenilacetic acid;
3,4-dihydroxyphenylacetaldehyde; and sulfoconjugated
derivatives) (D’Angelo et al., 2001) in animals were later
detected. Figure 1 shows different metabolites of
hydroxytyrosol including enzymatic pathways of
formation.
Recently, it has been determined hydroxytyrosol
and 3-o-methyl-hydroxytyrosol in plasma after
real-life doses of extra virgin olive oil (Miro-Casas et
al., 2003), finding that approximately 98% of
hydroxytyrosol appears to be present in plasma and
urine in glucuronide-conjugated forms, which
suggests extensive first-pass intestinal/hepatic
metabolism of the ingested hydroxytyrosol.
Into the enterocytes, ß-carotene can be
converted to vitamin A. This process is highly
regulated, and consequently toxic levels of vitamin A
from ingested carotenoids are rare (Olson, 1994).
Carotenoids distribute into lipoproteins (LDL) where
they exert antioxidant activities, and in tissues,
mainly adipose tissue (85%), liver (12%) and muscle
(3%). Particularly, lutein has been shown to suffer
oxidative modifications in human serum, forming
metabolites with anti-tumoral activities (Khachik et
al., 1995). In further studies, Khachik et al. (1997)
identified dehydrated metabolites of lutein.
Figure 1
Metabolites from hydroxytyrosol (adapted from Tuck et al., 2002).
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Tocopherols are metabolised in the liver, by a
pathway involving cytochrome P450-mediated
w-hydroxylation of the phytyl side chain followed by
stepwise removal of two- or three-carbon moieties,
ultimately yielding the 3-carboxychromanol
metabolite that is excreted in urine (Sontang and
Parker, 2002). The a-tocopherol transfer protein
(a-TTP) specifically binds a-tocopherol and sorts it
out for incorporation into plasma lipoproteins
(Schuelke et al., 2000), what suggests a high
regulation of the plasma and tissue levels of
a-tocopherol. That is in accordance to the fact that
only a-tocopherol, among other tocopherols, has
signalling functions in vascular smooth muscle cells
(Brigelius-Flohe and Traber, 1999; Azzi et al., 2000).
The metabolic pathway of the hepatic degradation of
a-tocopherol has not been fully established, but w-
and ß-oxidations probably occur after
w-hydroxylation, suggesting the participation of a
CYP3A-type cytochrome (Birringer t al., 2001).
Furthermore, the same authors pointed out that a
competition of microsomal w-oxidation with specific
binding by the a-TTP could determine the metabolic
fate of tocopherols.
Finally, some of these metabolites are recently
probed to have effects on cancer cell proliferation, by
specific down-regulation of cyclin expression (Galli et
al., 2004). The presence of vitamin E metabolites in
plasma is parallel to the ingested parent compounds,
as have been assessed by high performance liquid
chromatography (Lodge et al., 2001; Radosavac et al.,
2002) and gas-chromatography/mass spectrometry
(Galli et al., 2002 ).
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